FDA Inspection
AVEVA Drug Delivery Systems, Inc.AVEVA Drug Delivery Systems, Inc. – FDA Inspection, Apr 27, 2018
Record Details
This FDA Inspection record concerns AVEVA Drug Delivery Systems, Inc., with an inspection on April 27, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 183e1a8e-383a-4f7f-8019-a17b487fc165
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1049851
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.188(b)(12)Investigations made into any unexplained discrepancy
- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AVEVA Drug Delivery Systems, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | Not classified | Florida District Office | Drug Quality Assurance |
| September 1, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2019 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AVEVA Drug Delivery Systems, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.